129 related articles for article (PubMed ID: 25571292)
21. Effect of canagliflozin on the pharmacokinetics of glyburide, metformin, and simvastatin in healthy participants.
Devineni D; Manitpisitkul P; Murphy J; Skee D; Wajs E; Mamidi RN; Tian H; Vandebosch A; Wang SS; Verhaeghe T; Stieltjes H; Usiskin K
Clin Pharmacol Drug Dev; 2015; 4(3):226-36. PubMed ID: 27140803
[TBL] [Abstract][Full Text] [Related]
22. Effect of linagliptin (BI 1356) on the steady-state pharmacokinetics of simvastatin.
Graefe-Mody U; Huettner S; Stähle H; Ring A; Dugi KA
Int J Clin Pharmacol Ther; 2010 Jun; 48(6):367-74. PubMed ID: 20497745
[TBL] [Abstract][Full Text] [Related]
23. Concomitant use of cytochrome P450 3A4 inhibitors and simvastatin.
Gruer PJ; Vega JM; Mercuri MF; Dobrinska MR; Tobert JA
Am J Cardiol; 1999 Oct; 84(7):811-5. PubMed ID: 10513779
[TBL] [Abstract][Full Text] [Related]
24. Effect of pioglitazone on the pharmacokinetics of verapamil and its major metabolite, norverapamil, in rats.
Choi JS; Burm JP
Arch Pharm Res; 2008 Sep; 31(9):1200-4. PubMed ID: 18806964
[TBL] [Abstract][Full Text] [Related]
25. Effects of naringin on the pharmacokinetics of verapamil and one of its metabolites, norverapamil, in rabbits.
Kim HJ; Choi JS
Biopharm Drug Dispos; 2005 Oct; 26(7):295-300. PubMed ID: 16013069
[TBL] [Abstract][Full Text] [Related]
26. Disease-Drug Interaction of Sarilumab and Simvastatin in Patients with Rheumatoid Arthritis.
Lee EB; Daskalakis N; Xu C; Paccaly A; Miller B; Fleischmann R; Bodrug I; Kivitz A
Clin Pharmacokinet; 2017 Jun; 56(6):607-615. PubMed ID: 27722854
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of simvastatin lactone and its active metabolite simvastatin hydroxy acid in healthy Chinese male and female volunteers.
Yang W; Xu H; Song Y; Wang X; Ren X; Zhao D; Cai Y; Zhang S; Huang J; Zhang LR; Zhang T; Zuo M
Int J Clin Pharmacol Ther; 2014 Feb; 52(2):151-8. PubMed ID: 24290412
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of verapamil and norverapamil enantiomers after administration of immediate and controlled-release formulations to humans:evidence suggesting input-rate determined stereoselectivity.
Bhatti MM; Lewanczuk RZ; Pasutto FM; Foster RT
J Clin Pharmacol; 1995 Nov; 35(11):1076-82. PubMed ID: 8626881
[TBL] [Abstract][Full Text] [Related]
29. Study of the drug-drug interaction between simvastatin and cisapride in man.
Simard C; O'Hara GE; Prévost J; Guilbaud R; Masseé R; Turgeon J
Eur J Clin Pharmacol; 2001 Jun; 57(3):229-34. PubMed ID: 11497338
[TBL] [Abstract][Full Text] [Related]
30. Effect of benidipine on simvastatin metabolism in human liver microsomes.
Sugiyama Y; Mimura N; Kuwabara T; Kobayashi H; Ushiki J; Fuse E
Drug Metab Pharmacokinet; 2007 Jun; 22(3):199-205. PubMed ID: 17603221
[TBL] [Abstract][Full Text] [Related]
31. Opposite effect of diabetes mellitus induced by streptozotocin on oral and intravenous pharmacokinetics of verapamil in rats.
Hu N; Xie S; Liu L; Wang X; Pan X; Chen G; Zhang L; Liu H; Liu X; Liu X; Xie L; Wang G
Drug Metab Dispos; 2011 Mar; 39(3):419-25. PubMed ID: 21135265
[TBL] [Abstract][Full Text] [Related]
32. Role of esterase mediated hydrolysis of simvastatin in human and rat blood and its impact on pharmacokinetic profiles of simvastatin and its active metabolite in rat.
Li Z; Zhang J; Zhang Y; Zuo Z
J Pharm Biomed Anal; 2019 May; 168():13-22. PubMed ID: 30776567
[TBL] [Abstract][Full Text] [Related]
33. Simvastatin does not have a clinically significant pharmacokinetic interaction with fenofibrate in humans.
Bergman AJ; Murphy G; Burke J; Zhao JJ; Valesky R; Liu L; Lasseter KC; He W; Prueksaritanont T; Qiu Y; Hartford A; Vega JM; Paolini JF
J Clin Pharmacol; 2004 Sep; 44(9):1054-62. PubMed ID: 15317833
[TBL] [Abstract][Full Text] [Related]
34. Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin.
Lilja JJ; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 2000 Oct; 68(4):384-90. PubMed ID: 11061578
[TBL] [Abstract][Full Text] [Related]
35. Effects of regular consumption of grapefruit juice on the pharmacokinetics of simvastatin.
Lilja JJ; Neuvonen M; Neuvonen PJ
Br J Clin Pharmacol; 2004 Jul; 58(1):56-60. PubMed ID: 15206993
[TBL] [Abstract][Full Text] [Related]
36. Non-concurrent dosing attenuates the pharmacokinetic interaction between amlodipine and simvastatin.
Park CG; Lee H; Choi JW; Lee SJ; Kim SH; Lim HE
Int J Clin Pharmacol Ther; 2010 Aug; 48(8):497-503. PubMed ID: 20650039
[TBL] [Abstract][Full Text] [Related]
37. Development and Application of a Mechanistic Pharmacokinetic Model for Simvastatin and its Active Metabolite Simvastatin Acid Using an Integrated Population PBPK Approach.
Tsamandouras N; Dickinson G; Guo Y; Hall S; Rostami-Hodjegan A; Galetin A; Aarons L
Pharm Res; 2015 Jun; 32(6):1864-83. PubMed ID: 25446771
[TBL] [Abstract][Full Text] [Related]
38. Effects of HMG-CoA reductase inhibitors on the pharmacokinetics of losartan and its main metabolite EXP-3174 in rats: possible role of CYP3A4 and P-gp inhibition by HMG-CoA reductase inhibitors.
Yang SH; Choi JS; Choi DH
Pharmacology; 2011; 88(1-2):1-9. PubMed ID: 21709429
[TBL] [Abstract][Full Text] [Related]
39. Assessment of pharmacokinetic interaction between omega-3 carboxylic acids and the statins rosuvastatin and simvastatin: Results of 2 phase I studies in healthy volunteers.
Offman E; Davidson M; Nilsson C
J Clin Lipidol; 2017; 11(3):739-748. PubMed ID: 28506390
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of verapamil and its metabolite norverapamil from a buccal drug formulation.
Sawicki W; Janicki S
Int J Pharm; 2002 May; 238(1-2):181-9. PubMed ID: 11996822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]